These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 33331485)

  • 1. GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN GASTROINTESTINAL AND LIVER DISEASES: PROCEEDINGS OF A JOINT MEETING OF THE BRAZILIAN SOCIETY OF HEPATOLOGY (SBH), BRAZILIAN NUCLEUS FOR THE STUDY OF HELICOBACTER PYLORI AND MICROBIOTA (NBEHPM), AND BRAZILIAN FEDERATION OF GASTROENTEROLOGY (FBG).
    Barbuti RC; Schiavon LL; Oliveira CP; Alvares-DA-Silva MR; Sassaki LY; Passos MDCF; Farias AQ; Barros LL; Barreto BP; Albuquerque GBML; Alves AM; Navarro-Rodriguez T; Bittencourt PL
    Arq Gastroenterol; 2020; 57(4):381-398. PubMed ID: 33331485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probiotics, Prebiotics, and Synbiotics: Implications and Beneficial Effects against Irritable Bowel Syndrome.
    Simon E; Călinoiu LF; Mitrea L; Vodnar DC
    Nutrients; 2021 Jun; 13(6):. PubMed ID: 34203002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review.
    Li HY; Zhou DD; Gan RY; Huang SY; Zhao CN; Shang A; Xu XY; Li HB
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of probiotics, prebiotics, and synbiotics on the biochemical, clinical, and immunological markers, as well as on the gut microbiota of obese hosts.
    da Silva TF; Casarotti SN; de Oliveira GLV; Penna ALB
    Crit Rev Food Sci Nutr; 2021; 61(2):337-355. PubMed ID: 32156153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotics, Prebiotics, and Synbiotics in the Irritable Bowel Syndrome Treatment: A Review.
    Chlebicz-Wójcik A; Śliżewska K
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN MANAGEMENT OF OBESITY AND PREDIABETES: REVIEW OF RANDOMIZED CONTROLLED TRIALS.
    Barengolts E
    Endocr Pract; 2016 Oct; 22(10):1224-1234. PubMed ID: 27409822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review article: can bugs be drugs? The potential of probiotics and prebiotics as treatment for non-alcoholic fatty liver disease.
    Koopman N; Molinaro A; Nieuwdorp M; Holleboom AG
    Aliment Pharmacol Ther; 2019 Sep; 50(6):628-639. PubMed ID: 31373710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical effects and gut microbiota changes of using probiotics, prebiotics or synbiotics in inflammatory bowel disease: a systematic review and meta-analysis.
    Zhang XF; Guan XX; Tang YJ; Sun JF; Wang XK; Wang WD; Fan JM
    Eur J Nutr; 2021 Aug; 60(5):2855-2875. PubMed ID: 33555375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic methods of gut microbiota modification in colorectal cancer management - fecal microbiota transplantation, prebiotics, probiotics, and synbiotics.
    Kaźmierczak-Siedlecka K; Daca A; Fic M; van de Wetering T; Folwarski M; Makarewicz W
    Gut Microbes; 2020 Nov; 11(6):1518-1530. PubMed ID: 32453670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
    Harris LA; Baffy N
    Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiota on biotics: probiotics, prebiotics, and synbiotics to optimize growth and metabolism.
    Edwards PT; Kashyap PC; Preidis GA
    Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G382-G390. PubMed ID: 32755308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial Effects of Probiotics, Prebiotics, Synbiotics, and Psychobiotics in Inflammatory Bowel Disease.
    Wasilewski A; Zielińska M; Storr M; Fichna J
    Inflamm Bowel Dis; 2015 Jul; 21(7):1674-82. PubMed ID: 25822014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effects of Probiotics, Prebiotics and Synbiotics in Non-Alcoholic Fat Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Systematic Review.
    Carpi RZ; Barbalho SM; Sloan KP; Laurindo LF; Gonzaga HF; Grippa PC; Zutin TLM; Girio RJS; Repetti CSF; Detregiachi CRP; Bueno PCS; Mazuqueli Pereira ESB; Goulart RA; Haber JFDS
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IVTH BRAZILIAN CONSENSUS CONFERENCE ON HELICOBACTER PYLORI INFECTION.
    Coelho LGV; Marinho JR; Genta R; Ribeiro LT; Passos MDCF; Zaterka S; Assumpção PP; Barbosa AJA; Barbuti R; Braga LL; Breyer H; Carvalhaes A; Chinzon D; Cury M; Domingues G; Jorge JL; Maguilnik I; Marinho FP; Moraes-Filho JP; Parente JML; Paula-E-Silva CM; Pedrazzoli-Júnior J; Ramos AFP; Seidler H; Spinelli JN; Zir JV
    Arq Gastroenterol; 2018; 55(2):97-121. PubMed ID: 30043876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probiotics, prebiotics, and synbiotics to prevent or combat air pollution consequences: The gut-lung axis.
    Keulers L; Dehghani A; Knippels L; Garssen J; Papadopoulos N; Folkerts G; Braber S; van Bergenhenegouwen J
    Environ Pollut; 2022 Jun; 302():119066. PubMed ID: 35240267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics.
    Patel R; DuPont HL
    Clin Infect Dis; 2015 May; 60 Suppl 2(Suppl 2):S108-21. PubMed ID: 25922396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probiotics, prebiotics, and synbiotics in nonalcoholic fatty liver disease and alcohol-associated liver disease.
    Kaufmann B; Seyfried N; Hartmann D; Hartmann P
    Am J Physiol Gastrointest Liver Physiol; 2023 Jul; 325(1):G42-G61. PubMed ID: 37129252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.
    Distrutti E; Monaldi L; Ricci P; Fiorucci S
    World J Gastroenterol; 2016 Feb; 22(7):2219-41. PubMed ID: 26900286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Probiotics, Prebiotics and Synbiotics in the Treatment of Irritable Bowel Syndrome: A systematic review and meta-analysis.
    Asha MZ; Khalil SFH
    Sultan Qaboos Univ Med J; 2020 Feb; 20(1):e13-e24. PubMed ID: 32190365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of gut microbiome in nonalcoholic fatty liver disease: pro-, pre-, syn-, and antibiotics.
    Cho MS; Kim SY; Suk KT; Kim BY
    J Microbiol; 2018 Dec; 56(12):855-867. PubMed ID: 30377993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.